Media Partnership
Between Immune Discovery and 10th Antigen Specific Immune Tolerance Summit
The 10th Antigen-Specific Immune Tolerance Summit returns to Boston this March, bringing together biopharma leaders advancing next-generation therapies for autoimmune and allergic diseases. As the field enters a critical phase of clinical validation, discussions will focus on durable clinical efficacy, biomarkers of tolerance, antigen selection, and innovative delivery technologies. Featuring speakers from Diamyd Medical, COUR Pharmaceuticals, Integrated NanoTherapeutics, BreezeBio, Bonsai Biotherapeutics, Parvus Therapeutics, and more, the summit will provide insights into pivotal clinical data, novel mRNA and nanoparticle platforms, regulatory strategy, and investment priorities. Join the industry's only dedicated antigen-specific immune tolerance meeting to help shape the future of precision immunology.